This study finds that dual-stimuli responsive nanoparticles enhance drug penetration in pancreatic cancer, suggesting improved treatment options.
Pancreatic ductal adenocarcinoma (PDAC) remains a lethal malignancy due to late-stage diagnosis and dense fibrotic stroma that impedes penetration of drugs. In this study, a brand-new prodrug molecule was developed...
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: